Form 4: LeMaitre Vascular Director Roush Acquires Shares Upon PSU Settlement
SEC Form 4 Filing
Director John A. Roush acquired 204 shares of LeMaitre Vascular common stock upon settlement of a Performance Share Unit (PSU) award on February 28, 2025.
Summary
- On February 28, 2025, John A. Roush, a director of LeMaitre Vascular Inc., acquired 204 shares of common stock upon the settlement of a Performance Share Unit (PSU) award.
- The PSU award was granted on December 8, 2023, and vests in installments.
- Roush also acquired 1 share upon the release of dividend equivalent rights.
- Following these transactions, Roush directly owns 2,916 shares of LeMaitre Vascular Inc.
- A Limited Power of Attorney was granted, authorizing individuals to act on Roush's behalf for SEC filings.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions, which doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company directors.
Comparison to Industry Standards
- Tracking insider transactions is a standard practice in corporate governance and financial analysis.
- Companies like Medtronic, Boston Scientific, and Abbott also have similar insider transaction disclosures.
- The vesting schedule of the PSU award (1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years) is a typical vesting arrangement for executive compensation.
Stakeholder Impact
- Shareholders are informed about the transactions of company insiders, providing transparency.
- Employees may be affected by the vesting of PSUs, as it relates to their compensation.
Key Dates
| Date | Description |
|---|---|
| December 13, 2024 | Date of execution for the Limited Power of Attorney. |
| December 8, 2023 | Date the Performance Share Unit (PSU) award was granted. |
| February 28, 2025 | Date of common stock acquisition upon settlement of PSU award and release of dividend equivalent rights. |
| March 04, 2025 | Date of signature for the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.